Glutathione Storage and Stability: What Studies Report

The short answer, stated with its limits

Two questions dominate searches on this topic: how long a reconstituted glutathione solution remains usable, and whether glutathione requires refrigeration. Neither question has an answer in the peer-reviewed papers summarised on this page. None of the verified studies below was designed as a stability study: none measured glutathione concentration in a vial over weeks, none compared lyophilised powder against reconstituted solution, and none published a beyond-use date for any preparation. Any specific number circulating online — "good for 30 days", "stable for 8 hours" — does not come from the literature reviewed here, and this page does not repeat or endorse such figures.

What the literature does support is background context: glutathione is a small thiol-containing tripeptide whose defining chemical feature is that it readily gives up an electron and converts to an oxidised disulfide form. Researchers who study it routinely treat that reactivity as the central analytical problem. That chemistry, rather than any published shelf-life table, is what makes storage and handling a recurring question.

This page is for educational purposes only and is not medical advice; consult a licensed physician before making any health decision. Nothing here describes how any product should be stored, prepared, or used by an individual.

Why glutathione's chemistry drives the storage question

A 2023 review in Vitamins and Hormones described glutathione as the major low-molecular-weight thiol antioxidant in cells, present in a reduced form (GSH) and an oxidised disulfide form (GSSG), with the ratio between the two treated as an indicator of redox state (PMID 36707132). The same review discussed glutathione's role in detoxification and in scavenging reactive oxygen species — the very reactions that consume reduced glutathione. A separate 2023 review in Redox Biology examined glutathione within peroxisomal redox homeostasis and reported that glutathione pools are compartment-specific and dynamically maintained rather than static (PMID 37804696).

The practical implication drawn by analysts is straightforward: a molecule defined by its ability to be oxidised can shift toward its oxidised form whenever oxygen, oxidising contaminants, certain metal ions, or alkaline conditions are present. This is a general chemical principle described across the redox literature, not a measured shelf life for any particular vial, and it should not be converted into a storage rule.

Reduced versus oxidised is not the same as "degraded"

An important distinction appears in the redox literature: conversion of GSH to GSSG is a reversible, enzymatically managed process inside cells, where glutathione reductase regenerates the reduced form. A Current Protocols in Toxicology method chapter described the standard spectrophotometric assay for glutathione reductase activity, underscoring that laboratories quantify this recycling step as a routine measurement (PMID 23045061). In a sealed container with no enzyme system present, that regeneration does not occur — a point of chemistry, again, rather than a finding from a storage trial.

Lyophilised powder versus reconstituted solution

Across peptide chemistry generally, solid lyophilised material and material in aqueous solution are handled as two different stability situations, because hydrolysis, oxidation, and pH-dependent reactions require water to proceed at appreciable rates. That is a general laboratory-handling fact, and it is the reason research suppliers of peptide materials commonly label powders and solutions differently.

No study in the verified set compared lyophilised glutathione with reconstituted glutathione, quantified loss of the reduced form over time in a vial, or defined how long a solution retained a stated concentration. Statements that assign a fixed number of days to a reconstituted glutathione solution therefore have no support in the papers reviewed here.

Freeze–thaw: what one study actually measured

Freeze–thaw cycling is a standard concern for any biologic in solution. The closest relevant paper in the verified set comes from reproductive biology: a 2022 study in The Journal of Reproduction and Development supplemented a semen freezing extender with reduced glutathione and evaluated frozen–thawed bull semen along with in vitro fertilisation outcomes (PMID 34866119). Researchers in that study were testing whether added glutathione protected cells through the freeze–thaw process, which is a different question from whether glutathione itself survives freezing intact.

The distinction matters. The study reported biological endpoints in sperm and fertilisation, not the residual concentration of reduced glutathione in the extender after thawing. It therefore cannot be cited as evidence that glutathione tolerates freeze–thaw cycles without loss, nor as evidence that it does not.

Heat, matrix effects and reactivity in food systems

Glutathione's reactivity has been documented outside the pharmacology literature. A 2017 study in the Journal of Agricultural and Food Chemistry examined glutathione added to type I sourdough and reported measurable effects on the taste and texture of the resulting bread (PMID 28502176). That work is relevant to a storage page only as an illustration: a thiol compound placed into a complex, warm, fermenting matrix participated chemically in that system rather than sitting inert. It says nothing about how glutathione behaves in a sealed vial, and the study made no stability measurement.

Measuring glutathione is itself a technical problem

One reason storage claims are difficult to verify is that glutathione quantification is sensitive to sample handling. A 2017 Nature Communications paper described a method for quantitative real-time imaging of glutathione, and researchers reported that the approach allowed glutathione levels to be followed dynamically rather than only in destructive endpoint assays (PMID 28703127). The development of such tools reflects a long-standing methodological concern that glutathione status can change during sample collection and processing.

Enzyme-based approaches are also standard. The glutathione reductase activity protocol cited above sets out reaction conditions in detail, reflecting how tightly controlled such assays must be (PMID 23045061). A related 2022 study in Biomedicines examined glutathione-dependent enzymes in glial neoplasms and reported associations with immunohistochemical profiles, again relying on careful tissue-handling methodology (PMID 36289655). None of these papers addresses vial storage, but together they explain why credible stability data require dedicated analytical work that has not been published for the preparations people ask about.

Route of administration and the regulatory frame

Searches frequently distinguish oral from injectable glutathione. In the verified literature, oral supplementation has been tested in a controlled trial: a randomised controlled trial published in the European Journal of Nutrition administered oral glutathione at 250 mg or 1,000 mg per day for six months in adults and reported increases in body stores of glutathione compared with placebo (PMID 24791752). That study addressed absorption and body pools, not product stability.

For injectable use, a 2025 narrative review in Cureus examined the safety and efficacy of glutathione supplementation for skin lightening across routes and reported that the supporting evidence base was limited (PMID 40013212). As a regulatory matter, injectable glutathione for cosmetic skin lightening is not an approved drug product in the United States; preparations encountered outside approved products may be compounded or labelled for research use only, and such labelling carries no assurance of sterility, potency, or defined shelf life. This is general regulatory background, not legal advice.

Glutathione Safety: What Studies Report

The six-month randomised trial of oral glutathione at 250 mg and 1,000 mg daily reported increases in glutathione body stores and did not describe the intervention as producing serious adverse outcomes in the population studied (PMID 24791752). The 2025 narrative review of glutathione for skin lightening reported that safety and efficacy data remained limited and that further evidence was needed, particularly for non-oral routes (PMID 40013212). Broader reviews have described glutathione's physiological roles rather than a formal adverse-event profile (PMID 36707132). Safety findings in these papers relate to administration, not to degraded or improperly stored material, and no study reviewed here examined outcomes from compromised preparations.

Supplementation studies in animals, and why they do not settle storage

Several animal studies fed glutathione rather than injecting it. A 2020 study reported that dietary reduced glutathione supplementation improved growth, antioxidant capacity and immune measures in Chinese mitten crab (PMID 32135343), and a 2023 study reported that dietary glutathione attenuated oxidative stress and improved intestinal barrier measures in diquat-treated weaned piglets (PMID 37133420). Both involved glutathione incorporated into feed, and researchers reported biological endpoints rather than residual glutathione content in the diet over time. A 2024 commentary framed glutathione decline as a theme in ageing biology (PMID 39316535). None of these papers supports a storage or shelf-life claim.

What would be needed to answer the question properly

• Forced-degradation and real-time studies measuring reduced and oxidised glutathione in the same container across defined temperatures and time points.
• Head-to-head comparison of lyophilised powder against reconstituted solution using a validated assay.
• Defined freeze–thaw cycling data reporting residual content, distinct from biological-outcome studies such as the semen-extender work (PMID 34866119).
• Photostability and container-closure data, including headspace oxygen and material compatibility.
• Sterility and endotoxin data for any preparation intended for injection, which no verified study in this set evaluated.

Until such work is published and indexed, the honest summary is that the shelf life of a reconstituted glutathione solution and the need for refrigeration are undetermined in the literature reviewed here. Readers evaluating storage claims can reasonably ask which study, with which assay, produced the number being quoted.

References

• The antioxidant glutathione (Vitamins and Hormones, 2023)
• Randomized controlled trial of oral glutathione supplementation on body stores of glutathione (European Journal of Nutrition, 2015)
• Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review (Cureus, 2025)
• Quantitative real-time imaging of glutathione (Nature Communications, 2017)
• Effect of Glutathione on the Taste and Texture of Type I Sourdough Bread (Journal of Agricultural and Food Chemistry, 2017)
• Effects of reduced glutathione supplementation in semen freezing extender on frozen-thawed bull semen and in vitro fertilization (The Journal of Reproduction and Development, 2022)
• The Glutathione Theory of Aging (Alternative Therapies in Health and Medicine, 2024)
• Measurement of glutathione reductase activity (Current Protocols in Toxicology, 2001)
• Glutathione and peroxisome redox homeostasis (Redox Biology, 2023)
• Dietary reduced glutathione supplementation can improve growth, antioxidant capacity, and immunity on Chinese mitten crab, Eriocheir sinensis (Fish & Shellfish Immunology, 2020)
• Relationship between Glutathione-Dependent Enzymes and the Immunohistochemical Profile of Glial Neoplasms (Biomedicines, 2022)
• Dietary glutathione supplementation attenuates oxidative stress and improves intestinal barrier in diquat-treated weaned piglets (Archives of Animal Nutrition, 2023)